IIM
AVXL icon

INTECH Investment Management’s Anavex Life Sciences AVXL Stock Holding History

INTECH Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8K Sell
21,533
-2,066
-9% -$6.11K ﹤0.01% 2039
2026
Q1 		$72.4K Sell
23,599
-13,346
-36% -$57.8K ﹤0.01% 1956
2025
Q4 		$132K Hold
36,945
– – ﹤0.01% 2100
2025
Q3 		$329K Sell
36,945
-11,897
-24% -$121K ﹤0.01% 1786
2025
Q2 		$450K Buy
48,842
+16,589
+51% +$142K ﹤0.01% 1660
2025
Q1 		$277K Sell
32,253
-10,130
-24% -$95.7K ﹤0.01% 1935
2024
Q4 		$455K Buy
42,383
+18,827
+80% +$145K ﹤0.01% 1616
2024
Q3 		$134K Buy
+23,556
New +$136K ﹤0.01% 1829

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

INTECH Investment Management's AVXL Position: Q2 2026 in Review

INTECH Investment Management reduced its Anavex Life Sciences (AVXL) stake by 8.8% in Q2 2026, selling an estimated $6.11K and leaving 21,533 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

INTECH Investment Management first reported a position in AVXL in Q3 2024 and has held it in 8 quarters since. The position peaked at $455K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • INTECH Investment Management held 21,533 shares of Anavex Life Sciences worth $55.8K as of Q2 2026.
  • INTECH Investment Management sold 2,066 Anavex Life Sciences shares in Q2 2026, an estimated $6.11K.
  • Anavex Life Sciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2039 holding.
  • INTECH Investment Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Anavex Life Sciences position peaked at $455K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.